Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial

HIV endpoint–driven clinical trials provide oral pre-exposure prophylaxis (PrEP) as HIV prevention standard of care. We evaluated quantifiable plasma tenofovir among South African women who used oral PrEP during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial. METHODS: ECHO, a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Beesham, Ivana, Mansoor, Leila E., Joseph Davey, Dvora L., Palanee-Phillips, Thesla, Smit, Jenni, Ahmed, Khatija, Selepe, Pearl, Louw, Cheryl, Singata-Madliki, Mandisa, Kotze, Philip, Heffron, Renee, Parikh, Urvi M., Wiesner, Lubbe, Rees, Helen, Baeten, Jared M., Beksinska, Mags
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2022
Materias:
Prevention Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377486/
https://www.ncbi.nlm.nih.gov/pubmed/35972853
http://dx.doi.org/10.1097/QAI.0000000000003023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377486/
https://www.ncbi.nlm.nih.gov/pubmed/35972853
http://dx.doi.org/10.1097/QAI.0000000000003023

Ejemplares similares